Skip to main content
SpringerLink
Log in

Innovatività del farmaco: politiche, strumenti e metodi

  • Lettere Al Direttore
  • Published:
PharmacoEconomics Italian Research Articles

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Del Santo F, Maratea D, Messori A. Lettera al Direttore. Pharmacoeconomics-Italian Research Articles 2011; 13: 121–4

    Google Scholar 

  2. Apolone G, Patarnello F. The value of a drug: From innovation to the payment via Karl Marx. J Ambul Care Manage 2008; 31: 52–5

    PubMed  Google Scholar 

  3. Motola D, De Ponti F, Rossi P. Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. Br J Clin Pharmacol 2005; 59: 475–8

    Article  PubMed  Google Scholar 

  4. Italian Medicines Agency (AIFA) Research & Development Working Group. Feasibility and challenges of independent research on drugs: the Italian medicines agency (AIFA) experience. Eur J Clin Invest 2010; 40: 69–86

    Article  Google Scholar 

  5. Legge 29 novembre 2007, n. 222; Legge 27 dicembre 2002, n. 289

  6. Claxton K, Briggs A, Buxton MJ, et al. Value based pricing for NHS drugs: an opportunity not to be missed? BMJ 2008; 336: 251–4

    Article  PubMed  Google Scholar 

  7. Kopp C. What is a truly innovative drugs. New definition from the ISDB. Can Fam Physician 2002; 48: 1413–5

    PubMed  Google Scholar 

  8. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005; 331: 897–900

    Article  PubMed  Google Scholar 

  9. Ferner R, Hughes D, Aronson J. NICE and new: appraising innovation. BMJ 2010; 340: b5493

    Article  PubMed  Google Scholar 

  10. Aronson J. Something new every day: defining innovation and innovativeness in drug therapy. J Ambul Care Manage 2008; 31: 65–8

    PubMed  Google Scholar 

  11. Apolone G, Joppi R, Bertele’ V, et al. Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures. Br J Cancer 2005; 93: 504–9

    Article  PubMed  CAS  Google Scholar 

  12. Sobrero A, Bruzzi P. Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval. J Clin Oncol 2009; 27: 5868–73

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Direzione Payers and Evidence Solution, GSK, Verona, Italia

    Francesca Patarnello

  2. Direzione Scientifica, ASMN-IRCCS, Reggio-Emilia, Italia

    Giovanni Apolone

Authors
  1. Francesca Patarnello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Apolone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesca Patarnello.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patarnello, F., Apolone, G. Innovatività del farmaco: politiche, strumenti e metodi. Pharmacoeconomics-Ital-Res-Articles 14, 74–76 (2012). https://doi.org/10.1007/BF03320699

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03320699

Search

Navigation